Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q4G0F5

Entry ID Method Resolution Chain Position Source
AF-Q4G0F5-F1 Predicted AlphaFoldDB

217 variants for Q4G0F5

Variant ID(s) Position Change Description Diseaes Association Provenance
rs758627881
CA6372179
3 F>L No ClinGen
ExAC
gnomAD
rs1037338422
CA231245456
5 G>R No ClinGen
Ensembl
rs1224117576
CA383493537
8 Q>R No ClinGen
gnomAD
CA6372180
rs150789700
10 V>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA6372181
rs747138489
11 E>A No ClinGen
ExAC
TOPMed
gnomAD
CA383493556
rs1347279439
11 E>Q No ClinGen
gnomAD
CA383493565
rs1591874303
12 V>G No ClinGen
Ensembl
rs1050830778
CA231245466
12 V>M No ClinGen
TOPMed
CA383493928
rs1272604488
14 I>M No ClinGen
TOPMed
gnomAD
CA383493930
rs1166160486
15 L>V No ClinGen
TOPMed
rs377029699
CA231245468
16 L>P No ClinGen
Ensembl
TCGA novel 18 D>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1480395792
CA383493948
18 D>H No ClinGen
TOPMed
gnomAD
rs1480395792
CA383493949
18 D>Y No ClinGen
TOPMed
gnomAD
CA231245470
rs886849125
COSM1317354
19 A>G haematopoietic_and_lymphoid_tissue [Cosmic] No ClinGen
cosmic curated
TOPMed
rs1200836115
CA383493957
19 A>S No ClinGen
gnomAD
TCGA novel 21 S>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs74462513
CA231245472
21 S>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA383493991
rs1166887322
24 R>Q No ClinGen
TOPMed
gnomAD
rs1036512274
CA231245475
24 R>W No ClinGen
TOPMed
gnomAD
rs899357583
CA231245478
25 A>T No ClinGen
TOPMed
gnomAD
CA383494006
rs748498512
26 E>D No ClinGen
ExAC
gnomAD
CA383494010
rs1364775676
27 H>P No ClinGen
TOPMed
gnomAD
rs1364775676
CA383494011
27 H>R No ClinGen
TOPMed
gnomAD
CA6372186
rs371039042
30 E>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA383494032
rs371039042
30 E>G Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs762627075
CA6372187
31 D>N No ClinGen
ExAC
TOPMed
gnomAD
CA6372189
rs773684939
32 G>R No ClinGen
ExAC
TOPMed
gnomAD
CA6372191
rs759127190
33 K>E No ClinGen
ExAC
gnomAD
TCGA novel
CA383494066
rs1290009980
33 K>R Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
TOPMed
gnomAD
NCI-TCGA
CA383494064
rs1290009980
33 K>T No ClinGen
TOPMed
gnomAD
CA6372192
rs373569374
34 K>E No ClinGen
ESP
ExAC
gnomAD
rs752690816
CA383494087
34 K>N No ClinGen
ExAC
TOPMed
gnomAD
rs1425956800
CA383494089
35 E>K No ClinGen
TOPMed
CA383494148
rs1444718626
38 F>I No ClinGen
gnomAD
rs1191826980
CA383494176
39 L>F No ClinGen
gnomAD
rs1191826980
CA383494173
39 L>V No ClinGen
gnomAD
CA383494212
rs1161334800
41 Y>C No ClinGen
gnomAD
rs763813492
CA6372195
CA383494274
44 E>D No ClinGen
ExAC
gnomAD
rs1410702526
CA383494306
46 V>A No ClinGen
TOPMed
rs753649611
CA6372196
47 S>A No ClinGen
ExAC
gnomAD
rs1381638621
CA383494331
48 G>W No ClinGen
gnomAD
rs1317724622
CA383494360
50 V>L No ClinGen
gnomAD
CA6372198
rs780349854
53 A>S No ClinGen
ExAC
gnomAD
CA383494419
rs780349854
53 A>T No ClinGen
ExAC
gnomAD
CA383494450
rs1313224434
55 K>Q No ClinGen
gnomAD
rs1023897341
CA231245515
58 N>S No ClinGen
TOPMed
gnomAD
rs755131324
CA6372200
60 R>W No ClinGen
ExAC
gnomAD
CA231245519
rs200076063
61 L>P No ClinGen
1000Genomes
rs1591874499
CA383494573
62 E>G No ClinGen
Ensembl
CA383494609
rs1224847997
65 G>S No ClinGen
TOPMed
CA383494616
rs1205099881
66 I>L No ClinGen
gnomAD
CA231245528
rs1035067092
70 F>L No ClinGen
TOPMed
CA383494713
rs1181328153
71 I>F No ClinGen
TOPMed
gnomAD
TCGA novel 77 Y>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs746237444
CA6372244
77 Y>H No ClinGen
ExAC
gnomAD
CA383497334
rs1192969088
77 Y>S No ClinGen
gnomAD
rs981973943
CA231250791
79 D>N No ClinGen
TOPMed
gnomAD
CA231250800
rs370978210
80 R>C No ClinGen
ESP
CA6372247
rs746504494
80 R>H No ClinGen
ExAC
gnomAD
CA231250811
rs989206678
81 G>R No ClinGen
gnomAD
CA231250817
rs913207297
83 H>Q No ClinGen
TOPMed
CA383497464
rs1350956246
84 H>R No ClinGen
gnomAD
CA6372249
rs776430967
85 E>D No ClinGen
ExAC
gnomAD
rs748053554
CA6372250
89 L>V No ClinGen
ExAC
TOPMed
gnomAD
CA6372254
rs767817735
94 A>S No ClinGen
ExAC
TOPMed
gnomAD
rs767817735
CA383497628
94 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA231250850
rs775689975
95 R>Q No ClinGen
TOPMed
rs770181237
CA6372256
95 R>W No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 98 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA6372257
rs764201176
99 I>N No ClinGen
ExAC
gnomAD
CA383497694
rs1591879725
100 T>P No ClinGen
Ensembl
rs753875206
CA6372258
100 T>S No ClinGen
ExAC
gnomAD
CA383497720
rs1213634546
102 S>L No ClinGen
TOPMed
gnomAD
CA383497741
rs1565356498
104 A>T No ClinGen
Ensembl
CA6372261
rs184697812
106 D>N No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA383497841
rs1591879753
110 T>P No ClinGen
Ensembl
TCGA novel 111 H>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA383497878
rs1443067262
112 V>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
TCGA novel 113 E>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA6372264
rs746733630
115 P>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
TCGA novel 119 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA6372268
rs769731323
120 T>A No ClinGen
ExAC
TOPMed
gnomAD
CA383498029
rs1380092795
121 G>R No ClinGen
gnomAD
CA383498043
rs1284564917
122 Q>* No ClinGen
gnomAD
rs1381146508
CA383498055
123 N>D No ClinGen
gnomAD
TCGA novel 127 R>= Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA6372271
rs770915188
127 R>C No ClinGen
ExAC
gnomAD
rs997239900
CA231251016
127 R>H No ClinGen
TOPMed
rs140389768
CA231254902
129 F>L No ClinGen
ESP
TOPMed
CA6372299
rs201072669
131 R>C No ClinGen
ExAC
gnomAD
rs1477409536
CA383499006
131 R>H No ClinGen
gnomAD
CA6372300
rs751882827
132 A>V No ClinGen
ExAC
gnomAD
CA383499074
rs1426849194
135 S>R No ClinGen
gnomAD
rs1464288071
CA383499100
COSM466588
137 R>C kidney Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
rs147379113
CA6372302
139 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1043201395
CA231254941
141 V>F No ClinGen
TOPMed
gnomAD
CA383499172
rs1043201395
141 V>I No ClinGen
TOPMed
gnomAD
CA383499216
rs1343676735
143 K>N No ClinGen
gnomAD
CA6372304
rs752358559
144 E>A No ClinGen
ExAC
gnomAD
CA383499247
rs1591882366
145 M>T No ClinGen
Ensembl
CA383499243
rs1347357490
145 M>V No ClinGen
gnomAD
CA6372307
rs372253863
147 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs982822432
CA231254965
150 H>P No ClinGen
TOPMed
gnomAD
rs1591882378
CA383499374
151 T>A No ClinGen
Ensembl
rs1450485246
CA383499427
153 S>N No ClinGen
gnomAD
TCGA novel 153 S>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1474217216
CA383499547
158 L>P No ClinGen
gnomAD
CA383499625
rs1161546577
161 S>C No ClinGen
gnomAD
CA383499610
rs1431433967
161 S>P No ClinGen
TOPMed
gnomAD
rs781475558
CA6372312
163 K>R No ClinGen
ExAC
TOPMed
gnomAD
CA6372313
rs748256651
164 M>I No ClinGen
ExAC
gnomAD
rs1453730530
CA383499768
169 E>K No ClinGen
TOPMed
CA6372316
rs773229617
171 C>S No ClinGen
ExAC
gnomAD
CA6372315
rs773229617
171 C>Y No ClinGen
ExAC
gnomAD
CA6372317
rs771398178
176 F>S No ClinGen
ExAC
gnomAD
rs1343265147
CA383500031
179 N>S No ClinGen
TOPMed
gnomAD
rs1301209173
CA383500046
180 K>E No ClinGen
TOPMed
CA6372318
rs774888517
181 S>C No ClinGen
ExAC
gnomAD
rs759932615
CA6372319
182 K>R No ClinGen
ExAC
TOPMed
gnomAD
CA383501857
rs1458969286
187 D>G No ClinGen
gnomAD
rs764777364
CA6372345
189 I>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1397001036
CA383501918
193 I>V No ClinGen
gnomAD
rs763466532
CA6372350
200 I>L No ClinGen
ExAC
TOPMed
gnomAD
rs1330620735
CA383502019
202 I>L No ClinGen
gnomAD
CA6372351
rs777959091
202 I>M No ClinGen
ExAC
gnomAD
CA383502098
rs1255082256
207 I>V No ClinGen
gnomAD
rs374370712
CA6372352
208 D>G No ClinGen
ESP
ExAC
gnomAD
rs1248193556
CA383502140
209 I>V No ClinGen
gnomAD
CA383502212
rs1182833830
212 R>Q No ClinGen
gnomAD
CA231259759
rs1051455685
213 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA383502265
rs772426075
215 T>K No ClinGen
ExAC
TOPMed
gnomAD
CA6372356
rs772426075
215 T>M No ClinGen
ExAC
TOPMed
gnomAD
rs1346736700
CA383502325
218 G>V No ClinGen
TOPMed
CA6372359
rs769205837
220 N>S No ClinGen
ExAC
gnomAD
CA383502374
rs769205837
220 N>T No ClinGen
ExAC
gnomAD
rs1351755902
CA383502397
221 V>M No ClinGen
gnomAD
CA231259808
rs111401005
225 N>S No ClinGen
Ensembl
CA6372361
rs761503499
227 T>M No ClinGen
ExAC
TOPMed
gnomAD
rs1398683727
CA383502543
228 I>T No ClinGen
TOPMed
CA231259817
rs991788426
230 K>M No ClinGen
TOPMed
CA383502565
rs1249386226
230 K>Q No ClinGen
gnomAD
rs766206737
CA6372365
232 E>K No ClinGen
ExAC
gnomAD
rs751572708
CA6372366
233 I>S No ClinGen
ExAC
gnomAD
CA231259824
rs898962728
237 A>S No ClinGen
TOPMed
rs898962728
CA383502753
237 A>T No ClinGen
TOPMed
TCGA novel 240 R>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1420035360
CA383503086
242 E>Q No ClinGen
TOPMed
CA383503149
COSM687166
rs1392483854
245 P>L lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
TCGA novel 247 R>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA6372382
rs770542325
249 F>L No ClinGen
ExAC
gnomAD
rs1363976307
CA383503264
251 A>T No ClinGen
gnomAD
CA6372384
rs759419191
251 A>V No ClinGen
ExAC
gnomAD
CA6372387
rs760510761
252 G>R No ClinGen
ExAC
gnomAD
rs1591488133
CA383503293
253 Y>D No ClinGen
Ensembl
rs758550271
CA6372390
255 L>V No ClinGen
ExAC
TOPMed
gnomAD
rs766420440
CA6372391
256 T>M No ClinGen
ExAC
TOPMed
gnomAD
CA383503457
rs1244134308
259 M>I No ClinGen
gnomAD
CA383503442
rs1209657435
259 M>L No ClinGen
gnomAD
CA383503469
rs1472034375
260 R>Q No ClinGen
gnomAD
CA383503468
rs1565359334
260 R>W Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA231261050
rs768146294
262 I>S No ClinGen
Ensembl
CA383503524
rs1591488150
263 N>S No ClinGen
Ensembl
rs751714973
CA6372392
265 K>R No ClinGen
ExAC
TOPMed
gnomAD
rs1415136107
CA383503644
267 S>F No ClinGen
gnomAD
CA383503672
rs1217512115
268 V>A No ClinGen
TOPMed
rs146620670
CA6372394
270 Y>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA6372393
rs146620670
270 Y>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA6372395
rs748502635
276 L>P No ClinGen
ExAC
rs542416560
CA6372397
277 I>L No ClinGen
1000Genomes
ExAC
gnomAD
CA6372398
rs748905855
277 I>T No ClinGen
ExAC
TOPMed
gnomAD
rs1555057911
CA383503946
279 E>D No ClinGen
Ensembl
rs1303263162
CA383503991
282 R>Q No ClinGen
gnomAD
rs1447042634
COSM1676606
CA383503988
282 R>W haematopoietic_and_lymphoid_tissue [Cosmic] No ClinGen
cosmic curated
gnomAD
COSM1232372
CA383504024
rs1381214559
283 R>H large_intestine [Cosmic] No ClinGen
cosmic curated
gnomAD
TCGA novel 288 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA231261420
rs909350877
290 V>A No ClinGen
Ensembl
rs745367343
CA6372420
291 V>A No ClinGen
ExAC
gnomAD
CA6372422
rs774980807
292 L>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs879813172
CA231261422
294 R>Q No ClinGen
TOPMed
gnomAD
TCGA novel 294 R>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1427612035
CA383504718
297 D>V No ClinGen
gnomAD
CA383504725
rs1268037400
298 I>N No ClinGen
TOPMed
rs776450098
CA6372425
COSM1475278
299 V>I Variant assessed as Somatic; 0.0 impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA6372428
rs138823375
300 R>P No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA6372427
rs138823375
300 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA6372426
rs541989590
300 R>W No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 301 K>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs767640193
CA6372430
302 S>N No ClinGen
ExAC
CA383504755
rs1347990005
303 M>I No ClinGen
TOPMed
CA6372431
rs752838639
303 M>L No ClinGen
ExAC
gnomAD
CA383504753
rs1591488342
303 M>T No ClinGen
Ensembl
CA6372432
rs751395535
COSM1352758
304 S>T large_intestine [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
rs764547459
CA383504774
306 Q>L Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs764547459
CA6372433
306 Q>R No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 307 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA383504792
rs1555057961
309 I>V No ClinGen
Ensembl
CA6372436
COSM925182
rs778529826
313 R>C Variant assessed as Somatic; 4.644e-05 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA231261468
rs568925080
313 R>H No ClinGen
gnomAD
rs758058105
CA383504830
315 E>* No ClinGen
ExAC
TOPMed
gnomAD
rs758058105
CA6372438
315 E>K No ClinGen
ExAC
TOPMed
gnomAD
rs746535728
CA383504839
316 G>A No ClinGen
ExAC
gnomAD
rs773295674
CA6372439
316 G>C No ClinGen
ExAC
gnomAD
CA6372440
rs746535728
316 G>V No ClinGen
ExAC
gnomAD
rs1187696711
CA383504851
318 T>I No ClinGen
gnomAD
CA231261516
rs938347654
319 S>F No ClinGen
Ensembl
rs201480019
CA6372443
320 L>P No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 323 V>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA6372446
rs759776381
324 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA6372445
rs773146019
324 R>W No ClinGen
ExAC
TOPMed
gnomAD
rs368644780
CA6372447
325 T>A No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA383504888
rs1396919780
325 T>I No ClinGen
gnomAD
CA383504884
rs368644780
325 T>P No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1368264193
CA383504905
328 Q>* No ClinGen
gnomAD
TCGA novel 332 N>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1263608625
CA383504942
333 N>S No ClinGen
TOPMed
CA6372452
rs754369033
334 C>R No ClinGen
ExAC
gnomAD

No associated diseases with Q4G0F5

No regional properties for Q4G0F5

Type Name Position InterPro Accession
No domain, repeats, and functional sites for Q4G0F5

Functions

Description
EC Number
Subcellular Localization
  • Cytoplasm
  • Membrane; Peripheral membrane protein
  • Early endosome
  • Late endosome
  • Localizes to early and late endosomal structures (By similarity)
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

7 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
early endosome A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways.
endosome A vacuole to which materials ingested by endocytosis are delivered.
late endosome A prelysosomal endocytic organelle differentiated from early endosomes by lower lumenal pH and different protein composition. Late endosomes are more spherical than early endosomes and are mostly juxtanuclear, being concentrated near the microtubule organizing center.
phagocytic vesicle A membrane-bounded intracellular vesicle that arises from the ingestion of particulate material by phagocytosis.
retromer complex A conserved hetero-pentameric membrane-associated complex involved in retrograde transport from endosomes to the Golgi apparatus. The budding yeast retromer comprises Vps35p, Vps29p, Vps26p, Vps5p, and Vps17p. The mammalian complex shows slight variation in composition compared to yeast, and comprises SNX1 or SNX2, SNX5 or SNX6, VPS26A or VPS26B, VPS29, and VPS35.
retromer, cargo-selective complex The trimeric subcomplex of the retromer, believed to be closely associated with the membrane. This trimeric complex is responsible for recognizing and binding to cargo molecules. The complex comprises three Vps proteins in both yeast and mammalian cells: Vps35p, Vps29p, and Vps26p in yeast, and VPS35, VPS29 and VPS26A or VPS26B in mammals.

No GO annotations of molecular function

Name Definition
No GO annotations for molecular function

4 GO annotations of biological process

Name Definition
cellular response to interferon-gamma Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon gamma is the only member of the type II interferon found so far.
intracellular protein transport The directed movement of proteins in a cell, including the movement of proteins between specific compartments or structures within a cell, such as organelles of a eukaryotic cell.
regulation of macroautophagy Any process that modulates the frequency, rate or extent of macroautophagy.
retrograde transport, endosome to Golgi The directed movement of membrane-bounded vesicles from endosomes back to the trans-Golgi network where they are recycled for further rounds of transport.

10 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q0VD53 VPS26A Vacuolar protein sorting-associated protein 26A Bos taurus (Bovine) PR
O75436 VPS26A Vacuolar protein sorting-associated protein 26A Homo sapiens (Human) PR
P40336 Vps26a Vacuolar protein sorting-associated protein 26A Mus musculus (Mouse) PR
Q8C0E2 Vps26b Vacuolar protein sorting-associated protein 26B Mus musculus (Mouse) PR
Q6AY86 Vps26a Vacuolar protein sorting-associated protein 26A Rattus norvegicus (Rat) PR
O01258 vps-26 Vacuolar protein sorting-associated protein 26 Caenorhabditis elegans PR
Q28HT6 vps26a Vacuolar protein sorting-associated protein 26A Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
Q5BKM4 vps26b Vacuolar protein sorting-associated protein 26B Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
Q6TNP8 vps26a Vacuolar protein sorting-associated protein 26A Danio rerio (Zebrafish) (Brachydanio rerio) PR
Q6DH23 vps26bl Vacuolar protein sorting-associated protein 26B-like Danio rerio (Zebrafish) (Brachydanio rerio) PR
10 20 30 40 50 60
MSFFGFGQSV EVEILLNDAE SRKRAEHKTE DGKKEKYFLF YDGETVSGKV SLALKNPNKR
70 80 90 100 110 120
LEHQGIKIEF IGQIELYYDR GNHHEFVSLV KDLARPGEIT QSQAFDFEFT HVEKPYESYT
130 140 150 160 170 180
GQNVKLRYFL RATISRRLND VVKEMDIVVH TLSTYPELNS SIKMEVGIED CLHIEFEYNK
190 200 210 220 230 240
SKYHLKDVIV GKIYFLLVRI KIKHMEIDII KRETTGTGPN VYHENDTIAK YEIMDGAPVR
250 260 270 280 290 300
GESIPIRLFL AGYELTPTMR DINKKFSVRY YLNLVLIDEE ERRYFKQQEV VLWRKGDIVR
310 320 330
KSMSHQAAIA SQRFEGTTSL GEVRTPSQLS DNNCRQ